Amarin Corporation plc ( AMRN) - Key Metrics
AMRN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $2.03 | -$0.37 | $1.93 | $1.93 |
| 2026Q1 | $2.15 | -$0.50 | $0.30 | $0.30 |
| 2025Q4 | $2.36 | -$0.06 | $0.73 | $0.73 |
| 2025Q3 | $2.39 | -$0.37 | -$0.61 | -$0.61 |
| 2025Q2 | $3.51 | -$0.68 | $0.80 | $0.80 |
AMRN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.96 |
| 2026Q1 | 0% | -6.03 |
| 2025Q4 | 0% | -59.45 |
| 2025Q3 | 0% | -11.07 |
| 2025Q2 | 0% | -5.96 |
AMRN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 12.13% | 0% |
| 2026Q1 | 2.11% | 0% |
| 2025Q4 | 5.26% | 0% |
| 2025Q3 | -3.75% | 0% |
| 2025Q2 | 4.94% | 0% |
AMRN
Price: $12.17
52 week price:
Earnings Per Share: -1.20 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Ireland
Volume: 2.2 million
Ebitda: -8.2 millionMarket Capitalization: 255.4 million